ENXTPA:HO
ENXTPA:HOAerospace & Defense

Thales (ENXTPA:HO) Valuation Check After Recent Share Price Momentum Rebuild

With no single headline event driving attention today, Thales (ENXTPA:HO) is back on investors’ radars after a recent share price move. This has prompted closer scrutiny of its valuation and recent performance trends. See our latest analysis for Thales. The recent 7 day share price return of 7.9% and 1 month share price return of 10.6% suggest momentum is rebuilding, set against a 90 day share price decline of 6.4% and a much stronger 1 year total shareholder return of 80.5%. If this move in...
ENXTPA:EL
ENXTPA:ELMedical Equipment

Is LensCrafters’ Omnichannel Optometry Push Reframing EssilorLuxottica’s (ENXTPA:EL) Brand-led Competitive Edge?

LensCrafters, part of EssilorLuxottica, recently continued its Dedicated to Everyday Excellence 360-degree omnichannel campaign, featuring immersive in-store and digital experiences and spotlighting Independent Optometrist Dr. Anisha Haji’s commitment to patient care and leadership in optometry. This renewed campaign underlines EssilorLuxottica’s focus on professional expertise and consumer trust as differentiators in the competitive optical retail and eye-care market. Now we’ll examine how...
ENXTPA:SU
ENXTPA:SUElectrical

How Schneider Electric’s US$700 Million U.S. Expansion Will Impact Schneider Electric (ENXTPA:SU) Investors

In recent days, Schneider Electric announced plans to invest over US$700 million in its U.S. operations over the next two years, upgrading, expanding and opening facilities across multiple states and adding more than 1,000 jobs to support energy infrastructure, AI growth and domestic manufacturing. This move signals a deeper commitment to the U.S. market and energy security, potentially reinforcing Schneider Electric’s role in supplying critical infrastructure for AI and electrification...
ENXTPA:ERF
ENXTPA:ERFLife Sciences

Eurofins Scientific (ENXTPA:ERF) Valuation Check After Muted Returns And Efficiency Investment Plans

Eurofins Scientific (ENXTPA:ERF) is back in focus after recent share price moves, with investors weighing its €7,144.3m revenue base and €380.9m net income against mixed short term and multi year total returns. See our latest analysis for Eurofins Scientific. Recent trading has been fairly muted, with a 1 month share price return of 5.41% but a 3 year total shareholder return decline of 6.69% and a 5 year total shareholder return decline of 10.72%, suggesting longer term momentum has been...
ENXTPA:EXA
ENXTPA:EXAAerospace & Defense

European Value Stocks Estimated Below Intrinsic Worth January 2026

As the pan-European STOXX Europe 600 Index reaches new heights, buoyed by an improving economic environment and closing 2025 with its strongest annual performance since 2021, investors are increasingly turning their attention to stocks that may be trading below their intrinsic value. In this context of rising indices and a favorable economic climate, identifying undervalued stocks can present opportunities for those seeking to capitalize on potential market inefficiencies.